Evaluation of the Effects of vitamin D3 supplementation on Irritable bowel syndrome symptoms.
- Conditions
- Irritable Bowel Syndrome.Irritable bowel syndrome
- Registration Number
- IRCT201402234010N11
- Lead Sponsor
- ational Nutrition and Food Technology Research Institute (NNFTRI)
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 66
Inclusion criteria: age between 18 to 65 years old; serum level of 25(OH)D under 30 ng/ml; evidence of having irritable bowel syndrome using Rome III Criteria; not having Vitamin D supplementation since one year ago; not having a history of alcohol drink; not suffering from other organic diseases of the intestine, bowel surgery, breast; cancer, severe mental illness; not pregnant, breastfeeding and professional sports; not taking Non-steroidal anti-inflammatory drug ( NSAIDs), laxatives, nicotine, artificial sweeteners, antibiotics, immunomodulators or repression, intestinal bleeding, drugs, fish oils and digestive movements modifier.
Exclusion criteria: their unwillingness to continue the study for any reason; pregnancy.
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method 25 (OH) D. Timepoint: before and after studu (end of second month). Method of measurement: ELISA.;Constipation. Timepoint: before and after study (end of second month). Method of measurement: question.;Diarrhea. Timepoint: before and after study (end of second month). Method of measurement: question.;Bloating and abdominal pain. Timepoint: before and after study (end of second month). Method of measurement: question.
- Secondary Outcome Measures
Name Time Method